INTRODUCTION
============

Sunlight is crucial for life and has many beneficial effects, but, at the same time, the UV radiation (UVR) contained by sunlight is the most common environmental carcinogen ([@bib30]; [@bib6]). Unlike other mammals that have fur to protect their skin, human skin is constantly exposed to solar UVR (280--400 nm) and is susceptible to its damaging effects, primarily skin cancers and photoaging. Human skin also has a unique protection mechanism against UVR: the presence of melanocytes in the epidermis allows skin to respond to UVR by increasing its pigmentation. Because UVR is omnipresent and is able to interact with human skin, identifying the molecular pathways that allow human skin to detect and elicit an immediate response to UVR is critical for developing new photoprotective methods.

How does human skin detect UVR? UVR consists of photons; photons can activate G protein--coupled opsin receptors (GPCRs) in the eye that elicit cellular responses through the activation of different G proteins and downstream effectors. Gα~i/o~ is used by vertebrate photoreceptors ([@bib10]), whereas Gα~q/11~ mediates *Drosophila melanogaster* phototransduction ([@bib14]) and non-image forming vision in the mammalian retina ([@bib7]; [@bib27]; [@bib43]). Activation of Gα~q/11~ pathways leads to stimulation of phospholipase C β (PLCβ), which induces hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP~2~) into diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP~3~). Changes in the levels of PIP~2~, DAG, and IP~3~ modulate the activity of many proteins, including transient receptor potential (TRP) ion channels.

We recently characterized a retinal-dependent UVR-sensitive phototransduction pathway in human epidermal melanocytes (HEMs) that is G protein and PLCβ dependent and results in the activation of TRP subfamily A1 (TRPA1) channels; activation of this pathway results in a rapid increase in intracellular Ca^2+^ (\[Ca^2+^\]~ic~) and increased cellular melanin content ([@bib38]; [@bib5]). In this study we investigated the G protein that mediates this pathway and the downstream molecular events. We found that UVR phototransduction in HEMs is mediated by Gα~q/11~ signaling, and provide evidence for a phosphoinositide cascade involving IP~3~-mediated intracellular Ca^2+^ release via IP~3~ receptors (IP~3~R) and PIP~2~ regulation of Ca^2+^-permeable TRPA1 ion channels. The two sources of Ca^2+^ have different dynamics and, combined, result in a Ca^2+^ response with a fast rising phase and a slow decay. Our results demonstrate that UVR phototransduction in HEMs activates a Gα~q/11~-dependent signaling pathway similar to well-characterized phototransduction pathways in the eye.

MATERIALS AND METHODS
=====================

Reagents
--------

Cholera toxin (CTX), pertussis toxin (PTX), HC-030031, 1-oleoyl-2-acetyl-*sn*-glycerol (OAG), phosphatidylcholine phospholipase C (PC-PLC; from *Clostridia perfringens*), polylysine (PolyK, 70--150 kD), heparin, and ionomycin were purchased from Sigma-Aldrich. Endothelin, GPAnt-2, GPAnt-2a, and Xestospongin C (XeC) were from Tocris Bioscience. mSIRK and L9A were from EMD Millipore. DiC8-PIP2 was from Echelon Biosciences. Stocks of all reagents in water, DMSO, or ethanol were stored at −4°C or −20°C until use and diluted to the final concentration to contain \<1% solvent. For Ca^2+^ imaging experiments, HEMs were preincubated with pharmacological reagents for 3--15 min, with the exception of PTX and CTX, which used 24 h incubations.

Cell culture
------------

Primary HEMs isolated from neonatal foreskin were cultured in Medium 254 containing Human Melanocyte Growth Supplement (HMGS2; Cascade Biologics/Invitrogen) and 1% penicillin-streptomycin (Invitrogen), and propagated for a limited number of cell divisions (≤15). Vitamin A or retinoid derivatives are not components of either Medium 254 or HMGS2. Human embryonic kidney (HEK293) cells were cultured in Dulbecco's Modified Eagle Medium and F12 nutrient mixture (DMEM-F12; Gibco/Invitrogen) containing 10% fetal bovine serum (Atlanta Biologicals) and 1% penicillin-streptomycin (Invitrogen).

Molecular biology
-----------------

MicroRNAs (miRNAs) were designed and expressed in HEMs using a lentiviral system, as described previously ([@bib38]). BLOCK-iT miRNA oligos (Invitrogen) were cloned into the pcDNA6.2-GW/EmGFP-miR expression vector modified to contain mCherry instead of EmGFP to allow for simultaneous fluorescence detection and Fluo-4--based Ca^2+^ imaging. miRNAs were recombined from pcDNA6.2-GW into pDONR221 and pLENTI6/V5-DEST vectors (Invitrogen) for lentiviral production. Lentiviral particles containing miRNA were obtained as described previously ([@bib38]). HA-tagged RGS2 (Missouri S&T cDNA Resource Center) was recombined into pDONR221 and pLENTI6/V5-DEST vectors (Invitrogen) for lentiviral production as described previously ([@bib38]).

The mRNA expression level of Gα~q~, Gα~11~, or Gα~q/11~ in control or targeted miRNA-treated cells was determined ≥7 d after infection using comparative C~T~ quantitative PCR (qPCR). Total RNA was extracted from infected HEMs using the RNeasy Plus kit (QIAGEN) and converted to cDNA using RT-PCR (SuperScript III; Invitrogen). qPCR reactions were prepared according to manufacturer instructions using Power SYBR green. All reactions were done in triplicate and actin was used for normalization.

Western blots
-------------

Expression of HA-tagged RGS2 in HEMs was confirmed via Western blotting. Cells were homogenized ≥10 d after infection in ice-cold RIPA buffer (Thermo Fisher Scientific) containing protease inhibitor cocktail (Roche). Samples were agitated at 4°C for 30 min and then centrifuged at 16,000 *g* for 30 min at 4°C. Protein content was determined using the Pierce BCA Protein Assay kit (Thermo Fisher Scientific). Equal amounts of protein were loaded onto each lane, separated by electrophoresis on NuPAGE Bis-Tris gels (Invitrogen), and transferred to PVDF membranes (Roche). Membranes were blocked at room temperature for 1 h and incubated overnight at 4°C with rat monoclonal anti-HA antibody clone 3F10 (1:500; Roche), followed by 1 h at room temperature with HRP-conjugated goat anti--rat IgG affinity-purified antibody (1:5,000; EMD Millipore). Antibodies were detected using the SuperSignal West Femto enhanced chemiluminescence system (Thermo Fisher Scientific) and imaged using autoradiography film (Thermo Fisher Scientific).

Light stimulation
-----------------

Ultraviolet light stimulation of cultured HEMs was conducted using a 200 W Hg-Xe arc lamp with converging optics and appropriate filters ([@bib38]). A dichroic mirror (260--400 nm) was used in combination with 280-nm long pass and a 400-nm short pass filters (Newport). The levels of light lost due to scattering by imaging buffer were negligible. Physiological doses of UVR were applied by varying the duration and/or power of the pulse. A hand-held silicon detector was used to measure power (Newport).

Calcium imaging
---------------

Ca^2+^ imaging was performed as described previously ([@bib38]; [@bib5]). Cultured HEMs plated on glass coverslips were incubated for 15 min at room temperature in Ringer's solution with 2 µM Fluo-4 (Molecular Probes/Invitrogen) and 250 µM sulfinpyrazone (Sigma-Aldrich), followed by dark incubation for 15 min with 12 µM of 9-cis or all-trans retinal (Sigma-Aldrich). Imaging was performed in modified Ringer's extracellular solution containing (in mM): 150 NaCl, 1.8 CaCl~2~, 1.2 MgCl~2~, 10 D glucose, 25 HEPES, pH 7.4, and 310 mOsm/liter. Fluorescence images were acquired every 2 s, and 2 µM ionomycin (Sigma-Aldrich) was added at the end of some experiments to elicit a maximal Ca^2+^ response used for normalization.

The fluorescence intensity of individual cells (measured using ≥25% of the cell area, F~cell~) was quantified using MetaMorph (Molecular Devices) and MATLAB (MathWorks) and plotted in Prism 6 (GraphPad Software). F~cell~ values were normalized as F~norm~ = (F~cell~ − F~min~)/(F~iono~ − F~min~), where F~iono~ is maximal fluorescence with ionomycin, and F~min~ is baseline fluorescence averaged from ≥15 data points acquired before light stimulation. Final data values for each dish were obtained by averaging F~norm~ values from individual cells. In experiments where ionomycin was not used for normalization, Fluo-4 fluorescence intensities were quantified as ΔF/F~o~(t) = \[F~cell~(t) − F~baseline~\]/F~baseline~ and averaged as described previously. ΔF/F~o~ values were plotted as a function of time and fitted with a single-exponential function in Prism 6 (GraphPad Software) to calculate decay time constants. Ca^2+^ response initial slopes were calculated over the first 30 s after UVR stimulation.

Paired Ca^2+^ imaging experiments were used when the dish-to-dish variability was significant. Cells for each of the paired experiments were plated on glass coverslips and treated identically by incubation in the same Fluo-4 and retinal solution, then imaged sequentially in alternating order: control followed by experimental condition or experimental condition followed by control. The averaged fluorescence intensities of cells from one coverslip measured in each condition were plotted as the two experimental values connected by the dotted line. Statistical significance of paired experiments was evaluated using a paired Student's *t* test. When pairing is not mentioned, the cells were cultured and treated identically, but we did not strictly alternate control and experimental condition measurements. In such cases, we averaged the values from all the control and all the experimental conditions and represented them as bar graphs.

Electrophysiology
-----------------

Electrophysiology experiments were performed as described previously ([@bib5]). All-trans retinal was stored, solubilized, and applied as described previously ([@bib38]). Experiments were performed under dim-red or infrared illumination. Whole-cell patch clamp recordings were carried out using micropipettes with 3--6 MΩ resistance at room temperature using an EPC 10 amplifier (HEKA) with PatchMaster software (HEKA), filtered at 2.9 kHz and digitized at 20 kHz. Experiments were performed using modified Ringer's solution (see "Calcium imaging"). Unless stated otherwise, internal pipette solution contained (in mM): 140 CsCl, 1 MgCl~2~, 4 MgATP, 10 EGTA, 10 HEPES, pH 7.2, and 290 mOsm/liter. The low EGTA solution used in [Fig. S3](http://www.jgp.org/cgi/content/full/jgp.201311094/DC1){#supp1} contained 20 µM EGTA. UVR-induced currents were measured using a step protocol consisting of a step from a holding potential of −60 mV to +80 mV immediately before UVR exposure. Current values were calculated by subtracting initial current at +80 mV (I~o~) from maximal current after UVR exposure: I~UVR~ = I~max~ − I~o~. All recordings were inspected for baseline drift before analysis. In most recordings, the baseline did not drift significantly. If the baseline drift was \>20% of the UVR response, cells were excluded. Cell membrane capacitance values were used to calculate current densities. Current--voltage (I-V) relations were established using voltage step protocol from the −60-mV holding potential to voltages between −80 mV and +80 mV in 20-mV increments.

HEMs are very difficult to patch clamp. Our experiments are further complicated by the fact that UV exposure often causes us to lose patches. Because UV photocurrents are small and exhibit strong outward rectification ([@bib5]), most of our voltage-clamp experiments use positive membrane voltages that are not physiological (+80 mV) in order to increase current amplitude. Although current amplitude is higher at positive membrane voltages, current kinetics are significantly altered compared with recordings carried out at more physiological membrane voltages ([@bib4]). In addition, positive voltages are not well tolerated by these cells, preventing us from recording and plotting the current over a long period of time for every single trace. We have previously recorded currents over longer periods using voltage pulses ([@bib5]) and at more negative voltages ([@bib4]), and showed that the current returns to baseline after the UV pulse. Our success rate, even for the short periods of UV irradiation, is well below 10%. Consistent with the difficultly of these experiments, the large noise is likely caused by the relatively low seal resistance (∼1 GΩ) and patch stability.

Statistical analyses
--------------------

Experimental data are presented as mean ± SEM, where *n* refers to the number of dishes for imaging data or the number of cells for electrophysiology. We calculated p-values by unpaired or paired Student's *t* test and considered results significant when P ≤ 0.05.

Online supplemental material
----------------------------

Fig. S1 shows that RGS2 expression in HEMs reduces Ca^2+^ responses to endothelin. Fig. S2 shows that HEMs expressing Gα~q~-, Gα~11~-, or Gα~q/11~-targeted miRNA have reduced Ca^2+^ responses to endothelin. Fig. S3 shows that neither IP~3~-mediated Ca^2+^ release nor DAG activate the UVR photocurrent. Fig. S4 shows selective inhibition of UVR phototransduction signaling components versus ion channels by cellular dialysis. Online supplemental material is available at <http://www.jgp.org/cgi/content/full/jgp.201311094/DC1>.

RESULTS
=======

Identification of the Gα subunit that mediates UVR-induced Ca^2+^ responses in HEMs
-----------------------------------------------------------------------------------

We have recently shown that exposure to physiological doses of UVR activates a retinal-dependent phototransduction pathway that is mediated by G protein activation ([@bib38]; [@bib5]). However, we have yet to identify the type of G protein responsible for initiating the retinal-dependent signaling pathway activated by UVR. HEMs express a variety of GPCRs and their related G proteins, including the melanocortin-1 receptor coupled to Gα~s~ ([@bib29]) and the Gα~q/11~-coupled endothelin-1B (ET-1) receptor ([@bib42]; [@bib17]).

Because we previously showed that UVR exposure leads to retinal-dependent Ca^2+^ responses ([@bib38]), we monitored intracellular Ca^2+^ levels using the fluorometric Ca^2+^ indicator Fluo-4 in response to treatments that modulate the function of different G protein subunits. We first tested if UVR-induced Ca^2+^ responses in HEMs were mediated by members of the Gα~s~ or Gα~i/o~ family. CTX treatment inhibits Gα~s~-mediated signaling and PTX inhibits Gα~i/o~ signaling ([@bib3]; [@bib22]). HEMs incubated for 24 h with 500 ng/ml CTX, 500 ng/ml PTX, or vehicle, and stimulated with 150 mJ/cm^2^ UVR showed no difference in the amplitude of retinal-dependent Ca^2+^ responses ([Fig. 1, A and B](#fig1){ref-type="fig"}; amplitude of the response: F~norm,\ max~ = 0.55 ± 0.04 for vehicle, 0.56 ± 0.05 for CTX, 0.52 ± 0.04 for PTX). This result suggests that Ca^2+^ responses elicited by physiological doses of UVR (150 mJ/cm^2^; [@bib38]) are not mediated by Gα~s~ or Gα~i/o~ signaling.

The Gβγ subunit of heterotrimeric G proteins can lead to increase in intracellular Ca^2+^ levels (\[Ca^2+^\]~ic~) by directly activating PLCβ ([@bib28]; [@bib40]; [@bib2]). To test if UVR-mediated elevation in \[Ca^2+^\]~ic,~ requires activation of Gβγ, we incubated HEMs with the Gβγ-inhibiting peptide mSIRK (10 µM) or its inactive analogue L9A (10 µM; [@bib12]; [@bib23]; [@bib36]) before stimulation with 150 mJ/cm^2^ UVR. No significant difference was measured between UVR-induced Ca^2+^ responses in HEMs treated with mSIRK compared with the inactive analogue L9A ([Fig. 1, C and D](#fig1){ref-type="fig"}; F~norm,max~ = 0.43 ± 0.05 for mSIRK vs. 0.43 ± 0.04 for L9A), which suggests Gβγ does not mediate UVR-induced Ca^2+^ responses in HEMs.

![Impaired Gα~q/11~ signaling, but not Gα~s~, Gα~i/o~, or Gβγ signaling, diminishes UVR-induced Ca^2+^ responses in HEMs. (A) HEMs treated with the Gα~s~ signaling inhibitor CTX (500 ng/ml), the Gα~i/o~ inhibitor PTX (500 ng/ml), or vehicle (water) have similar retinal-dependent Ca^2+^ responses (F~norm~) to 150 mJ/cm^2^ UVR. Each trace was normalized to the response elicited by ionomycin (iono., 1 µM), added at the end of each experiment. *n* = 7--10 cells from one experiment averaged for each trace. (B) The mean peak Ca^2+^ responses (F~norm,max~) elicited by 150 mJ/cm^2^ UVR were not altered when HEMs were treated with CTX or PTX, as compared with vehicle control. *n* = 7 experiments per condition, ±SEM (error bars). (C) HEMs stimulated with 150 mJ/cm^2^ UVR and treated with the Gβγ peptide inhibitor mSIRK (10 µM) or its inactive analogue L9A (10 µM) had similar retinal-dependent Ca^2+^ responses (F~norm~). *n* = 6--10 cells from one experiment averaged for each trace. (D) Mean UVR-induced (150 mJ/cm^2^) peak retinal-dependent Ca^2+^ responses (F~norm,\ max~) were not significantly different in HEMs treated with the Gβγ peptide inhibitor mSIRK versus its inactive analogue L9A. *n* = 9 paired experiments. (E) HEMs expressing RGS2 exhibited reduced retinal-dependent Ca^2+^ responses (F~norm~) to 150 mJ/cm^2^ UVR compared with control (mCherry-transfected) cells. *n* = 3--11 cells from one experiment averaged for each trace. (F) In paired experiments the mean amplitude of the retinal-dependent Ca^2+^ responses (F~norm,max~) in RGS2-expressing HEMs stimulated with UVR (150 mJ/cm^2^) was diminished compared with control cells. *n* = 8 experiments per condition, P \< 0.004. (G) qPCR analysis of mRNA levels of Gα~q/11~ family members (Gα~q~, Gα~11~, Gα~14~, and Gα~15~) in HEMs, relative to actin. Bars represent mean ± SEM (error bars) from *n* = 3 independent experiments.](JGP_201311094_Fig1){#fig1}

We next investigated whether members of the Gα~q/11~ family, known to promote Ca^2+^ mobilization through PLCβ activation ([@bib32]; [@bib34]), mediate the UVR-induced Ca^2+^ response. To alter Gα~q/11~ signaling, we expressed RGS2 in HEMs ([@bib16]; [@bib15]; [@bib31]), a member of the regulators of G protein signaling (RGS) family, which inactivates Gα~q/11~ by promoting the hydrolysis of GTP to GDP ([@bib9]). Lentiviral transduction of HA-RGS2 in HEMs resulted in the expression of a protein of the expected molecular size ([Fig. S1 A](http://www.jgp.org/cgi/content/full/jgp.201311094/DC1){#supp2}) that reduced Ca^2+^ responses to activation of the Gα~q/11~-coupled endothelin receptors endogenously present in HEMs ([@bib42]; [@bib17]; Fig. S1, B and C). Because HEMs expressing HA-RGS2 exhibited reduced Gα~q/11~-mediated signaling via endothelin receptors, we tested if UVR-induced Ca^2+^ responses were also reduced. When compared with control transduced HEMs, cells expressing HA-RGS2 stimulated with 150 mJ/cm^2^ UVR had significantly reduced retinal-dependent Ca^2+^ responses ([Fig. 1, E and F](#fig1){ref-type="fig"}; F~norm,max~ = 0.62 ± 0.03 for control vs. 0.37 ± 0.06 for RGS2), which suggests that members of the Gα~q/11~ family mediate UVR signaling in HEMs. To determine which members of the Gα~q/11~ family are expressed in HEMs and might be activated by UVR, we examined the mRNA expression levels of Gα~q/11~ family members Gα~q~, Gα~11~, Gα~14~, and Gα~15~ by qPCR. We found that in HEMs Gα~q~ and Gα~11~ are expressed at similarly high levels, whereas Gα~14~ and Gα~15~ are expressed at lower levels ([Fig. 1 G](#fig1){ref-type="fig"}).

Both Gα~q~ and Gα~11~ contribute to the UVR-induced Ca^2+^ response in HEMs
---------------------------------------------------------------------------

We investigated the contribution of Gα~q~ versus Gα~11~ to UVR signaling using RNA interference. Because Gα~q~ and Gα~11~ share a high degree of homology, we designed miRNA targeting either Gα~q~ or Gα~11~ individually, or both Gα~q~ and Gα~11~ (Gα~q/11~). Expression of Gα~q~-targeted miRNA in HEMs resulted in a significant reduction in the mRNA transcript levels of Gα~q~, but not of Gα~11~, relative to control (scrambled) miRNA-expressing cells ([Fig. 2 A](#fig2){ref-type="fig"}; Gα~q~ mRNA relative to control = 0.14 ± 0.01, Gα~11~ mRNA relative to control = 0.83 ± 0.16). Cells expressing Gα~q~-targeted miRNA had a reduced Ca^2+^ response to 6 nM endothelin when compared with control miRNA-expressing cells, which suggests that Gα~q~-targeted miRNA significantly reduced Gα~q~ signaling (Fig. S2, A and B). We then measured retinal-dependent Ca^2+^ responses elicited by 150 mJ/cm^2^ UVR and found that HEMs expressing Gα~q~-targeted miRNA had significantly reduced Ca^2+^ responses compared with HEMs expressing control miRNA ([Fig. 2, B and C](#fig2){ref-type="fig"}; F~norm,max~ = 0.57 ± 0.04 for control miRNA, 0.35 ± 0.03 for Gα~q~ miRNA).

![Gα~q~ and Gα~11~ signaling contribute to UVR-induced Ca^2+^ responses. (A) HEMs expressing Gα~q~-targeted miRNA had significantly reduced (∼85%) Gα~q~ levels, but not Gα~11~ mRNA levels compared with control miRNA-expressing cells (ctrl). *n* = 4 experiments, P \< 0.0001, ±SEM (error bars). (B) Retinal-dependent Ca^2+^ responses (F~norm~) to 150 mJ/cm^2^ UVR were reduced in HEMs expressing Gα~q~-targeted versus control miRNA. Each trace represents the average of 5--10 cells from one experiment. (C) In paired experiments, HEMs expressing Gα~q~-targeted miRNA had reduced mean peak retinal-dependent Ca^2+^ responses (F~norm,max~) compared with control miRNA-expressing HEMs. *n* = 6 experiments per condition, P \< 0.009. (D) HEMs expressing Gα~11~-targeted miRNA had Gα~11~ mRNA levels reduced by ∼90% and Gα~q~ transcript levels reduced by ∼20%, compared with control miRNA-expressing cells. *n* = 4 experiments, ±SEM (error bars). (E) Retinal-dependent Ca^2+^ responses (F~norm~) induced by 150 mJ/cm^2^ UVR were reduced in HEMs expressing Gα~11~-targeted miRNA relative to control miRNA-expressing cells. Each trace represents the average of 3--10 cells from one experiment. (F) HEMs expressing Gα~11~-targeted miRNA elicited smaller mean peak retinal-dependent Ca^2+^ responses (F~norm,max~) compared with control miRNA-expressing cells. *n* = 8, P \< 0.008. (G) miRNA targeting a conserved region of Gα~q~ and Gα~11~ (Gα~q/11~) reduced the mRNA transcript levels of Gα~q~ by ∼75% and of Gα~11~ by ∼70%, relative to control miRNA-expressing cells. *n* = 4, ±SEM (error bars). (H) Pseudochrome fluorescence images of HEMs loaded with Ca^2+^ indicator and preincubated with retinal. (H, top) Images of HEMs expressing control miRNA recorded before UVR stimulation (baseline) and at the peak of the Ca^2+^ response to 150 mJ/cm^2^ UVR (UVR). (H, bottom) Images of HEMs expressing Gα~q/11~-targeted miRNA before UVR stimulation (baseline) and at the peak of the UVR-induced Ca^2+^ response (UVR). HEMs expressing Gα~q/11~-targeted miRNA showed a reduced fluorescence response to UVR compared with control miRNA (bottom vs. top UVR). (I) HEMs expressing Gα~q/11~-targeted miRNA had reduced retinal-dependent Ca^2+^ responses evoked by 150 mJ/cm^2^ UVR compared with HEMs expressing control miRNA. Each trace represents the average of *n* = 4--10 cells from one experiment. (J) The mean peak UVR-induced Ca^2+^ response measured in paired experiments in HEMs expressing Gα~q/11~-targeted miRNA was reduced compared with control miRNA. *n* = 8, P \< 0.0001.](JGP_201311094_Fig2){#fig2}

Expression of Gα~11~-targeted miRNA resulted in a significant reduction in the mRNA levels of Gα~11~ (Gα~11~ mRNA relative to control = 0.12 ± 0.03) and a smaller decrease in the mRNA transcript levels of Gα~q~ ([Fig. 2 D](#fig2){ref-type="fig"}; Gα~q~ mRNA relative to control = 0.75 ± 0.07). HEMs expressing Gα~11~-targeted miRNA had reduced Ca^2+^ responses to 6 nM endothelin ([Fig. S2, C and D](http://www.jgp.org/cgi/content/full/jgp.201311094/DC1){#supp3}), which suggests that Gα~11~ signaling is also reduced. In response to stimulation with 150 mJ/cm^2^ UVR, HEMs expressing Gα~11~-targeted miRNA had a reduced retinal-dependent Ca^2+^ response compared with HEMs expressing control miRNA (F~norm,max~ = 0.61 ± 0.04 for control miRNA, 0.40 ± 0.05 for Gα~11~ miRNA; [Fig. 2, E and F](#fig2){ref-type="fig"}). Collectively, our data from HEMs expressing Gα~q~ or Gα~11~-targeted miRNA suggest that both Gα~q~ and Gα~11~ contribute to the UVR-induced retinal-dependent phototransduction pathway in HEMs.

We next examined if decreasing Gα~q~ and Gα~11~ levels simultaneously had a larger effect on UVR-induced Ca^2+^ responses in HEMs. Expression of Gα~q/11~ miRNA that targets both Gα~q~ and Gα~11~ significantly reduced the mRNA levels of Gα~q~ and Gα~11~ relative to control miRNA-expressing cells ([Fig. 2 G](#fig2){ref-type="fig"}; Gα~q~ mRNA relative to control = 0.24 ± 0.08, Gα~11~ mRNA relative to control = 0.32 ± 0.08). Stimulation with 6 nM endothelin resulted in reduced Ca^2+^ responses in HEMs expressing Gα~q/11~-targeted compared with control miRNA (Fig. S2 E and [Fig. 2 F](#fig2){ref-type="fig"}; F~norm,max~ = 0.72 ± 0.04 for control miRNA, 0.44 ± 0.07 for Gα~q/11~ miRNA). UVR stimulation of HEMs expressing Gα~q/11~-targeted miRNA led to smaller increases in intracellular Ca^2+^ levels compared with control miRNA-treated cells ([Fig. 2 H](#fig2){ref-type="fig"}). Quantification of these responses showed that the UVR-induced Ca^2+^ responses were significantly reduced in the presence of Gα~q/11~-targeted miRNA compared with control miRNA ([Fig. 2, I and J](#fig2){ref-type="fig"}), which suggests that both subunits Gα~q~ and Gα~11~ contribute to retinal-dependent UVR-induced Ca^2+^ responses in HEMs.

UVR stimulation of HEMs leads to activation of a whole-cell current mediated by TRPA1 ion channels in a retinal and G protein--dependent manner ([@bib5]). We thus investigated if Gα~q/11~ is also required for UVR-induced whole-cell currents. We first tested the effect of Gα~q/11~-targeted miRNA on whole-cell currents measured at +80 mV in response to 240 mJ/cm^2^ UVR and found that expression of control miRNA had no effect on the photocurrents, whereas Gα~q/11~-targeted miRNA nearly abolished them ([Fig. 3, A and B](#fig3){ref-type="fig"}; I~UVR/ctrl\ miRNA~ = 4.06 ± 0.29 pA/pF, I~UVR/\ Gαq/11\ miRNA~ = 0.28 ± 0.17 pA/pF) at all voltages ([Fig. 3 B](#fig3){ref-type="fig"}, inset). The whole-cell patch clamp technique used to measure the photocurrents allowed us to use an alternative method to block Gα~q/11~ signaling by dialyzing GPAnt-2a, a Gα~q/11~ inhibitory peptide, into HEMs ([@bib24]). The time-dependent effect of peptide inhibitor dialysis allowed us to measure the UVR-induced current at 2 min after break-in, when the peptide was not effective, and thus the measurement was used as control, and at 10 min of dialysis, when the peptide became effective. This experimental protocol allowed us to compare the effects of the peptide inhibitors in the same cell. When GPAnt-2a was included in the pipette solution, the UVR photocurrents were similar to control cells 2 min after break-in, but decreased significantly after 10 min of dialysis ([Fig. 3, E and F](#fig3){ref-type="fig"}; I~UVR/GPAnt-2a~ = 3.98 ± 0.50 pA/pF at 2 min, 0.69 ± 0.08 pA/pF after 10 min of dialysis with GPAnt-2a). As a control we performed a similar experiment using the GPAnt-2 peptide, which inhibits Gα~i/o~ signaling ([@bib24]), and detected no change in the amplitude of the UVR current after 2 or 10 min of dialysis ([Fig. 3, C and D](#fig3){ref-type="fig"}; I~UVR/GPAnt-2~ = 3.68 ± 0.49 pA/pF at 2 min, 3.64 ± 0.26 pA/pF after 10 min). These results suggest that UVR-induced photocurrents are dependent on Gα~q/11~ signaling.

![Gα~q/11~ mediates the retinal-dependent UVR photocurrent in HEMs. (A) Expression of Gα~q/11~-targeted miRNA in a representative HEM abolished the UVR (240 mJ/cm^2^)-induced whole-cell current at +80 mV exhibited in cells expressing control miRNA. Recordings were performed from two populations of cells: one expressing control miRNA and the other expressing Gα~q/11~-targeted miRNA. (B) HEMs expressing Gα~q/11~-targeted miRNA had an ∼93% lower mean peak UVR photocurrent density compared with those expressing control miRNA. *n* = 8 cells per condition, P \< 0.0001, ±SEM (error bars). (B, inset) UVR-induced increase in current density versus voltage in a representative HEM-expressing control or Gα~q/11~-targeted miRNA. (C) Gα~i~/Gα~o~ signaling inhibitor peptide GPAnt-2 (40 µM) did not affect the UVR photocurrents after 10 min of patch pipette dialysis in a representative HEM (traces from the same cell). (D) The mean peak UVR photocurrent density was similar when GPAnt-2 (40 µM) was included in the patch pipette and HEMs were stimulated with UVR 2 or 10 min after break-in. *n* = 6 cells per condition. Error bars indicate ±SEM. (E) Gα~q/11~ signaling inhibitor peptide GPAnt-2a significantly reduced the UVR photocurrent after 10 min compared with 2 min of patch pipette dialysis in a representative HEM (traces from the same cell). The broken horizontal lines represent the baseline current for each recording. (F) The mean peak UVR photocurrent was reduced by ∼83% in HEMs dialyzed with GPAnt-2a for 10 min, compared with 2 min. *n* = 6 cells per condition, P \< 0.0001, ±SEM (error bars).](JGP_201311094_Fig3){#fig3}

UVR-activated TRPA1 photocurrents are regulated by PIP~2~ in HEMs
-----------------------------------------------------------------

Our results so far indicate that UVR phototransduction leads to activation of Gα~q/11~, which in turn activates PLCβ, required both for intracellular Ca^2+^ release ([@bib38]) and TRPA1 activation ([@bib5]). Nonetheless, the mechanism by which UVR leads to TRPA1 activation downstream of PLCβ remains unknown. Because PLCβ hydrolyzes plasma membrane PIP~2~, generating DAG and the soluble messenger IP~3~, we reasoned that PLCβ-dependent signaling could modulate TRPA1 channel activity in HEMs via IP~3~, DAG, or PIP~2~.

We first tested whether IP~3~ or IP~3~-mediated Ca^2+^ release was sufficient to activate TRPA1 by using a control internal solution, allowing for an increase in \[Ca^2+^\]~ic~ (see Materials and methods), internal solutions containing 100 µM IP~3~ to stimulate IP~3~Rs, or 1 mg/ml heparin to block IP~3~Rs, with both treatments occluding subsequent UVR-induced IP~3~R-mediated Ca^2+^ release. UVR (240 mJ/cm^2^) exposure after dialysis for 5 min with each of the three solutions elicited retinal-dependent photocurrents with similar amplitudes (Fig. S3, A and B; I~UVR/Ctrl~ = 4.01 ± 0.33 pA/pF, I~UVR/IP3~ = 4.04 ± 0.47 pA/pF, I~UVR/heparin~ = 5.05 ± 0.56 pA/pF), which suggests that UVR-induced activation of whole-cell currents is not mediated by IP~3~ or IP~3~R-mediated Ca^2+^ release.

We next examined the contribution of DAG to retinal-dependent UVR photocurrents. Bath application of the PC-PLC (10 U/ml), which generates DAG in the plasma membrane ([@bib25]), or of the DAG analogue OAG (100 µM), did not elicit a significant current in HEMs, and 5 min of incubation with the respective treatments did not affect the retinal-dependent photocurrents elicited by UVR (Fig. S3, C and D; I~PC-PLC~ = 0.10 ± 0.10 pA/pF, I~OAG~= 0.20 ± 0.09 pA/pF, I~UVR/PC-PLC~ = 4.31 ± 0.70 pA/pF, I~UVR/OAG~ = 4.13 ± 0.48 pA/pF). Because increasing DAG levels failed to elicit whole-cell currents and had no effect on UVR photocurrents, we concluded that DAG does not modulate TRPA1 downstream of UVR.

PIP~2~ hydrolysis is a key regulator for many ion channels ([@bib33]), including TRPA1 ([@bib8]; [@bib18]; [@bib19]). To test if the presumed decrease in PIP~2~ levels caused by PLCβ-mediated hydrolysis affects UVR photocurrents, we attempted to maintain elevated PIP~2~ levels by dialyzing HEMs with the PIP~2~ analogue diC8-PIP~2~ (20 µM; [@bib18]; [@bib19]). We found that after 5 min of patch pipette dialysis to allow diC8-PIP~2~ to diffuse into cells, UVR stimulation (240 mJ/cm^2^) elicited significantly smaller photocurrents at all voltages compared with UVR photocurrents measured immediately after break-in ([Fig. 4, A, B, and D](#fig4){ref-type="fig"}). This finding suggests that increased PIP~2~ prevents UVR-induced TRPA1 activation and raises the question of whether PIP~2~ hydrolysis is required for the UVR photocurrent.

To test if the dialysis with diC8-PIP~2~ inhibited TRPA1, or another component of the UVR phototransduction cascade, we compared the whole-cell currents elicited by UVR and the TRPA1 agonist cinnamaldehyde (CA) in HEMs dialyzed with diC8-PIP~2~ or GPAnt-2a ([Fig. S4](http://www.jgp.org/cgi/content/full/jgp.201311094/DC1){#supp4}). We found that dialysis with both diC8-PIP~2~ and GPant-2a inhibited UVR photocurrents, whereas only diC8-PIP~2~ inhibited currents elicited by CA (Fig. S4). These data suggest that GPAnt-2a inhibits an important component of the UVR signaling cascade, Gα~q/11~, while diC8-PIP~2~ directly inhibits TRPA1 activity, which is required for both the UVR- and CA^2+^-elicited increase in whole-cell current.

To test if a decrease in PIP~2~ levels is also sufficient to cause TRPA1 activation in HEMs, we dialyzed cells with polylysine (polyK; 50 mg/ml), which binds and sequesters PIP~2~ ([@bib21]; [@bib20]; [@bib35]), preventing it from acting on the TRPA1 channels. A subsaturating UVR dose (160 mJ/cm^2^; [@bib5]) evoked a submaximal UVR photocurrent in HEMs dialyzed with control internal solution. PolyK alone, when included in the pipette solution and allowed to diffuse into the cell and sequester PIP~2~, did not lead to an increase in whole-cell current; however, it significantly enhanced UVR photocurrents elicited by the same subsaturating UVR dose ([Fig. 4, C and E](#fig4){ref-type="fig"}; I~PolyK~ = 0.07 ± 0.03 pA/pF, I~UVR/Ctrl~ = 2.51 ± 0.07 pA/pF, I~UVR/PolyK~ = 4.90 ± 0.44 pA/pF). The polyK-modulated UVR photocurrent was inhibited by the TRPA1 antagonist HC-030031 (HC; 100 µM; [Fig. 4 C](#fig4){ref-type="fig"}, right; and [Fig. 4 E](#fig4){ref-type="fig"}; I~UVR/PolyK+HC~ = 0.27 ± 0.12 pA/pF), which suggests that the enhanced photocurrent was mediated by TRPA1.

![PIP~2~ regulates UVR-activated TRPA1 currents. (A) The UVR (240 mJ/cm^2^)-induced whole-cell current of a representative HEM dialyzed with the PIP~2~ analogue diC8-PIP~2~ and measured at +80 mV immediately after break-in was significantly reduced after 5 min of dialysis to allow diC8-PIP~2~ to diffuse into the cell. (B) HEMs dialyzed with diC8-PIP2 had reduced UVR photocurrent densities at all voltages when stimulated after 5 min of dialysis, compared with immediately after break-in. (C) HEMs exposed to a submaximal UVR dose (160 mJ/cm^2^) elicited a small but significant increase in whole-cell current at +80 mV (first trace). Including poly-lysine (polyK, 50 mg/ml) in the patch pipette did not alter the baseline current, but significantly potentiated the UVR (160 mJ/cm^2^)-induced current after 5 min of dialysis (second and third trace from the same representative cell). The augmented UVR-induced current measured in the presence of polyK was abolished by treatment with the TRPA1 antagonist HC-030031 (HC; 100 µM; fourth trace). (D) Dialysis with diC8-PIP~2~ reduced mean peak UVR photocurrents by ∼93% compared with control. *n* = 7 cells, P \< 0.0001, ±SEM (error bars). (E) PolyK dialysis did not elicit a significant increase in mean current density in the absence of UVR stimulation, but increased retinal-dependent photocurrents induced by 160 mJ/UVR by ∼96%. This effect was abolished by HC. *n* = 6 cells per condition, P \< 0.0008, ±SEM (error bars). (F) The UVR photocurrent induced by 160 mJ/cm^2^ UVR in a representative HEM was enhanced after 7 min of dialysis with PLCδ-PH (60 µM), when compared with boiled PLCδ-PH (60 µM) or GRP1-PH (60 µM). The broken horizontal lines represent the baseline current for each recording. (G) Dialysis of HEMs with PLCδ1-PH (60 µM) enhanced mean peak UVR photocurrents by ∼128% compared with cells dialyzed with boiled PLCδ1-PH (60 µM) or GRP1-PH (60 µM). *n* = 7--8 cells per condition, P \< 0.002, ±SEM (error bars).](JGP_201311094_Fig4){#fig4}

To address the specificity of the phospholipids that modulate the UVR photocurrents, we used recombinant pleckstrin homology (PH) domains from phospholipase C δ1 (PLCδ1-PH) that selectively bind PIP~2~ and from the general receptor for phosphoinositides type 1 (GRP1-PH) that selectively binds PI(3,4,5)P~3~ (PIP~3~; [@bib20]). Dialysis of recombinant PH domains in HEMs will bind and sequester the phosphoinotides, resulting in decreased cellular levels. When PLCδ1-PH was included in the pipette, a significantly enhanced photocurrent was elicited by a subsaturating UVR dose (160 mJ/cm^2^), compared with boiled PLCδ1-PH or GRP1-PH ([Fig. 4, F and G](#fig4){ref-type="fig"}; I~PLCδ1-PH~ = 3.01 ± 0.36 pA/pF, I~Boiled\ PLCδ1-PH~ = 1.32 ± 0.26 pA/pF, I~GRP1-PH~ = 1.34 ± 0.24 pA/pF). These results suggest that sequestering PIP~2~, but not PIP~3~, levels in HEMs leads to increased TRPA1 activity in response to UVR, leading us to hypothesize that UVR-mediated PIP~2~ hydrolysis releases the PIP~2~-mediated inhibition of TRPA1.

IP~3~R and TRPA1 mediate UVR-induced Ca^2+^ responses and regulate Ca^2+^ signaling kinetics
--------------------------------------------------------------------------------------------

Retinal-dependent UVR-induced Ca^2+^ responses triggered downstream of Gα~q/11~ signaling are mediated by two sources of Ca^2+^: (1) efflux from intracellular thapsigargin-sensitive stores and (2) influx via TRPA1 at the plasma membrane ([@bib5]). Because Gα~q/11~/PLCβ signaling generates the second messenger IP~3~, we hypothesized that IP~3~Rs mediate Ca^2+^ release from intracellular stores. To test this hypothesis, we treated HEMs with the IP~3~R antagonist XeC (25 µM; [@bib11]; [@bib26]) and found that UVR-induced Ca^2+^ responses were significantly reduced ([Fig. 5, A and B](#fig5){ref-type="fig"}). To study the contribution of each Ca^2+^ source (IP~3~R vs. TRPA1) to the overall response, we measured Ca^2+^ responses in HEMs preincubated with XeC in order to inhibit IP~3~R, or HC-030031 (HC; 100 µM) in order to inhibit TRPA1 ([Fig. 4 A](#fig4){ref-type="fig"}). Ca^2+^ responses elicited by 240 mJ/cm^2^ UVR were reduced by 71% in the presence of XeC, by ∼45% in the presence of HC, and by ∼90% in the presence of both antagonists, as compared with vehicle-treated cells ([Fig. 4 B](#fig4){ref-type="fig"}; fluorescence increase over baseline: ΔF/F~o~ = 3.21 ± 0.27 for vehicle, 0.94 ± 0.16 for XeC, 1.77 ± 0.29 for HC, and 0.34 ± 0.07 for XeC + HC). These results suggest that UVR phototransduction evokes a rise in \[Ca^2+^\]~ic~ via intracellular Ca^2+^ release from IP~3~R and Ca^2+^ influx through TRPA1 ion channels.

![IP~3~R and TRPA1 activity mediate UVR-induced Ca^2+^ responses and regulate signaling kinetics. (A) In HEMs the amplitudes of the retinal-dependent Ca^2+^ responses induced by 240 mJ/cm^2^ UVR in the presences of vehicle (1% DMSO) were reduced by the IP~3~R antagonist XeC (25 µM) and the TRPA1 antagonist HC-030031 (HC; 100 µM), and further reduced in the presence of both XeC and HC. *n* = 10--15 cells per condition. (B) Mean peak UVR-induced Ca^2+^ responses in the presence of vehicle were reduced by ∼71% in the presence of XeC, by ∼45% in the presence of HC, and by ∼90% by the coapplication of XeC and HC, respectively. *n* = 6 experiments per condition. P \< 0.0001 for XeC versus control, P \< 0.007 for HC versus control, P \< 0.0001 for XeC + HC versus control, ±SEM (error bars). (C) Analysis of the first 30 s of the UVR-induced Ca^2+^ response showed that treatment with XeC or HC reduced the initial slope compared to vehicle control. *n* = 10--15 cells from one experiment per condition. The broken lines represent the slopes of the initial increase in calcium (the straight line that fits the initial phase of the calcium response curve). The tangents of the angles formed by these lines with the x axis are represented in D (ΔF/s). (D) The mean initial slope of the Ca^2+^ response measured during the first 30 s after the beginning of UVR stimulation was reduced by ∼76% when cells were treated with XeC and by ∼35% when cells were treated with HC, compared with vehicle-treated cells. *n* = 6 experiments per condition. P \< 0.0001 for XeC versus control, P \< 0.03 for HC versus control, ±SEM (error bars). (E) The decay of the UVR-induced Ca^2+^ response (τ~off~), calculated by fitting the responses with a single exponential, was significantly longer in HEMs treated with XeC and reduced in HEMs treated with HC, compared with vehicle-treated cells. *n* = 10--15 cells per condition. The broken lines represent the exponential curve that fits the decreasing part of the calcium response shown in A. The exponential coefficient of these curves represents τ~off~, shown in F. (F) The mean τ~off~ of UVR-induced Ca^2+^ response decay in HEMs treated with vehicle was increased by ∼79% in the presence of XeC and reduced by ∼38% in the presence of HC. *n* = 6 experiments per condition. P \< 0.03 for XeC versus control, P \< 0.03 for HC versus control, ±SEM (error bars).](JGP_201311094_Fig5){#fig5}

We next sought to distinguish the contribution of each Ca^2+^ source (IP~3~R and TRPA1) to the biphasic nature of the transient UVR-induced Ca^2+^ response. To do that, we measured the initial slope and the decay time constant of Ca^2+^ responses in HEMs treated with XeC or HC, compared with vehicle. The mean initial slope of UVR-induced Ca^2+^ responses (measured during the first 30 s after the beginning of UVR stimulation) was reduced by ∼76% with XeC treatment and by ∼35% with HC treatment when compared with vehicle-treated HEMs ([Fig. 5, C and D](#fig5){ref-type="fig"}; ΔF/s = 0.100 ± 0.009 for vehicle, 0.024 ± 0.003 for XeC, and 0.064 ± 0.01 for HC). These results suggest that both sources contribute to the initial rising phase of the Ca^2+^ response, but IP~3~-mediated Ca^2+^ release has a significantly greater contribution.

The time constant for the decay phase (τ~off~) of the UVR-induced Ca^2+^ response was measured by monitoring cellular Ca^2+^ levels for ≥200 s after the peak of the response in cells treated with XeC, HC, or vehicle. HEMs treated with XeC had Ca^2+^ responses with mean τ~off~ values ∼79% higher than vehicle-treated cells, which suggests that the IP~3~-mediated response decays on a fast time scale. Interestingly, treatment with HC resulted in UVR-evoked Ca^2+^ responses that decayed ∼38% faster than vehicle-treated cells ([Fig. 5, E and F](#fig5){ref-type="fig"}; τ~off~ = 225.90 ± 37.44 s for XeC, 78.42 ± 12.68 s for HC, and 126.20 ± 10.61 s for vehicle). Hence, TRPA1 activation extends the duration of the Ca^2+^ responses, whereas IP~3~R activation reduces the duration. Collectively, our results suggest that IP~3~R-mediated Ca^2+^ release is important to ensure a fast rising phase of the response. In contrast, consistent with our previous findings ([@bib4]; [@bib5]), TRPA1 activation is slow but persistent, contributing to a prolonged Ca^2+^ response ([Fig. 6 B](#fig6){ref-type="fig"}).

![Proposed mechanism for the UVR phototransduction cascade in HEMs. (A) UVR stimulates a G protein--coupled receptor in a retinal-dependent manner, and leads to activation of Gα~q/11~ and PLCβ, which hydrolyzes PIP~2~ into DAG and IP~3~. PIP~2~ hydrolysis regulates the activity of TRPA1 at the plasma membrane to mediate Ca^2+^ influx, whereas IP~3~ activates IP~3~R to mediate Ca^2+^ release from intracellular stores. The increase in intracellular Ca^2+^ leads to early melanin synthesis. (B) Predicted contribution of IP~3~R- and TRPA1-mediated Ca^2+^ responses to UVR-induced Ca^2+^ signaling kinetics. IP~3~R contributes to the rapid initial increase in Ca^2+^, whereas TRPA1 contributes to sustained Ca^2+^ influx.](JGP_201311094_Fig6){#fig6}

DISCUSSION
==========

We have recently discovered that primary human melanocytes are capable of rapidly detecting UVR by first increasing intracellular Ca^2+^ and later producing more melanin ([@bib38]). The Ca^2+^ response is retinal dependent and is in part due to calcium release from intracellular stores and in part to calcium influx through TRPA1 ion channels ([@bib5]). Both components of the response require heterotrimeric G proteins and PLCβ activation ([@bib38]; [@bib5]). Here we investigated the identity of the G protein subunit that mediates the response and found that reducing the expression of both Gα~q~ and Gα~11~, as well as using a peptide that inhibits Gα~q/11~ signaling, significantly decreased both components of the Ca^2+^ response ([Figs. 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}). These results suggest that the UVR-activated pathway is mediated by Gα~q/11~, which, in turn, activates PLCβ.

Signal transduction pathways associated with G protein activation often result in modulation of TRP ion channels. For example, in *Drosophila*, light stimulation of rhodopsin results in activation of Gα~q/11~ and PLCβ, which hydrolyzes PIP~2~ to produce DAG and IP~3~, to regulate TRP ion channels ([@bib14]). We reasoned that one of these messengers (IP~3~, DAG, or PIP~2~) might regulate the UVR-activated TRPA1 photocurrent and tested our hypothesis by exogenously altering the levels of these messengers ([Figs. 4](#fig4){ref-type="fig"} and S3). We found that reagents used to manipulate the levels of IP~3~ and DAG had no effect on the photocurrent, whereas reagents that affect PIP~2~ levels did. Allowing diC8-PIP~2~ to diffuse into the cell blocked the current in response to a UVR dose that evokes a maximal response, which suggests that decreasing PIP~2~ levels is a necessary step in TRPA1 activation. But is the decrease in PIP~2~ sufficient to activate TRPA1?

Sequestration of PIP~2~ using polyK did not elicit a significant current in the absence of UVR, but did potentiate TRPA1 currents evoked by UVR. Furthermore, using PLCδ1-PH to specifically sequester PIP~2~ enhanced UVR photocurrents, whereas sequestration of PIP~3~ by GRP1-PH had no effect. These results suggest that a decrease in PIP~2~ can modulate the photocurrent, but may not be sufficient for TRPA1 activation. Therefore, other messengers or proteins that contribute to the phototransduction pathway could be involved. Our results add to the already controversial role of PIP~2~ in modulating TRPA1. PIP~2~ was found to potentiate agonist-activated TRPA1 currents ([@bib18]), but also to inhibit TRPA1 activity ([@bib8]; [@bib19]). GPCRs that activate Gα~q/11~ (bradykinin, PAR2, and Mrgprs) can regulate TRPA1, but the mechanism is unclear ([@bib1]; [@bib8]; [@bib37]; [@bib39]). It remains to be determined in future experiments whether PIP~2~ directly interacts with TRPA1 to modulate its activity and what other cellular messengers contribute to TRPA1 activation in response to UVR and to Gα~q/11~-coupled receptors.

Examining the relative contribution of UVR-induced IP~3~R- and TRPA1-mediated Ca^2+^ responses revealed that IP~3~-mediated Ca^2+^ release is rapid, but also declines fast. In contrast, TRPA1-mediated influx is slower to increase intracellular Ca^2+^, as suggested by the slow time course of the photocurrent activation, and slow to decay, allowing intracellular Ca^2+^ to remain elevated after UVR exposure, a necessary step for melanin production ([@bib5]). However, there is a discrepancy between the time course of photocurrents and that of Ca^2+^ responses. UVR photocurrents recorded under voltage-clamp conditions peak during or shortly after light stimulation, whereas Ca^2+^ responses measured in intact cells, in which the membrane voltage could change, peak seconds after irradiation. We recently found that UVR phototransduction depolarizes the plasma membrane of melanocytes to delay TRPA1 inactivation and prolong Ca^2+^ responses ([@bib4]), a finding consistent with the TRPA1-mediated influx kinetics found in this study. The discrepancy between the time course of the response measured by the two methods is likely to be caused by the significant effects of membrane depolarization on the TRPA1 channel and consequent Ca^2+^ signaling dynamics. Our analyses of Ca^2+^ response dynamics also revealed the possibility of cross-talk between the Ca^2+^ release and influx pathways. Inhibition of IP~3~R resulted in a significantly slower decline of the TRPA1-mediated Ca^2+^ response, which suggests that the IP~3~-mediated response decays considerably faster than the overall response. However, when TRPA1 was inhibited, the decay of the IP~3~-mediated Ca^2+^ responses was only slightly (although significantly) faster, which suggests that Ca^2+^ release may accelerate TRPA1 inactivation.

Based on our data, we propose that UVR exposure of HEMs stimulates a retinal-dependent Gα~q/11~-coupled receptor, which activates PLCβ. Active PLCβ hydrolyzes plasma membrane PIP~2~ into DAG and IP~3~. Soluble IP~3~ binds IP~3~Rs in the ER, resulting in Ca^2+^ release, whereas the decrease in PIP~2~ levels modulates TRPA1 activation and Ca^2+^ influx ([Fig. 6](#fig6){ref-type="fig"}). Our model for UVR signal transduction in human melanocytes resembles visual phototransduction in *Drosophila* photoreceptors ([@bib14]) and nonvisual phototransduction in the mammalian retina ([@bib7]; [@bib13]). The melanocyte UVR pathway also shares many similarities with a recently described UVR-activated signaling mechanism in *Drosophila* larvae, which is mediated by Ca^2+^ signals resulting from Gα~q/11~ and TRPA1 activation ([@bib41]). The receptor for the *Drosophila* larvae UVR pathway appears to be a gustatory GPCR (Gr28b); how light can activate such a receptor remains unknown.

One of the remaining questions for the UVR phototransduction cascade in melanocytes is the identity of the receptor. The retinal dependence and G protein involvement suggests the involvement of an opsin GPCR. We previously found that rhodopsin expression contributes to UVR-induced Ca^2+^ responses ([@bib38]). However, the differences in spectral sensitivity and G protein coupling of rhodopsin and of the UVR pathway suggest that rhodopsin might work in conjunction with a different, possibly unidentified, UVR-sensitive receptor to mediate UVR phototransduction in melanocytes. Future experiments will identify the UVR receptor and determine the molecular mechanism of TRPA1 activation. Understanding this pathway might uncover new photoprotection strategies for human skin, thus lowering the incidence of skin cancer.
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